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A B S T R A C T 
The mortality rate in gastric cancer during pregnancy is very high, which dictates the need to research 
and improve the methods of early diagnosis of malignancies, as well as studying the pathogenesis of 
malignant tumors in pregnant women. We report a lethal case of gastric cancer in a pregnant woman. 
The findings of the autopsy, histological, histochemical and immunohistochemical examinations 
verified gastric signet ring cells carcinoma with multiple metastases and infiltration of the placental 
intervillous space. The possible pathogenesis of cancer with changes in the hormonal background 
occurring in pregnant women is discussed. Understanding the endocrine mechanisms of carcinoma 
pathogenesis will be useful for developing new therapies for gastric cancer. 
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1. Introduction 
Gastric cancer is one of the most common malignancies, ranking fourth 
worldwide in terms of cancer type. Despite the gradual reduction in the 
incidence of gastric cancer, and, consequently, the reduction in mortality 
rate from this type of malignant tumors among men and women, gastric 
cancer ranks second, accounting for 9.7% of all cancer-related deaths [1]. 
Gastric cancer is characterized by the significant geographical variability, 
showing a 15 to 20-fold difference between the highest and lowest risk 
regions. More than 50% of new cases are diagnosed in developing 
countries [2]. 
Depending on the cause of gastric cancer and the processes that precede 
its development, intestinal and diffuse types are identified. Diffuse cancer 
is characterized by infiltrative growth and is represented by poorly 
organized groups or single cells with a high content of mucin (signet ring 
cells). The findings of clinical observations show that an unfavorable 
prognosis for diffuse gastric cancer is associated with late diagnosis, rapid 
progress, more potential of malignant tumor cells and early metastasis [3].  
Moreover, the progress of gastric cancer during pregnancy is of great 
interest, since it is a rare combination and is diagnosed mainly during 
advanced stages. 
We report a lethal case of gastric cancer with multiple metastases and 
infiltration of the intervillous space in a pregnant woman.  
2. Case report 
The 31-year-old female patient Z. (pregnant, II ) was admitted to the 
Perinatal Center of the Poltava Regional Clinical Hospital from the 
Central District Hospital at 31 weeks of gestation and was diagnosed with  
Ca ventriculi T4N1M1 (carcinomatosis of the abdominal cavity), post-
chemotherapy status (2017) and severe anemia. The patient experienced 
melanorrhagia and was vomiting blood. 
Upon hospitalization, the patient’s general conditions were grave. She 
complained of general weakness, dizziness, nausea and was vomiting 
blood. The patient was subjected to clinical, laboratory and instrumental 
examinations. 
The following procedures were performed: lower midline laparotomy, 
corporal caesarean section, extirpation of the uterus and uterine adnexa, 
exploration and drainage of the abdominal cavity. Diagnosis after surgery: 
pregnancy II, 31-32 weeks of gestation, cephalic presentation, fetal 
distress during pregnancy, placental dysfunction, Ca ventriculi T4N1M1, 
carcinomatosis of the abdominal cavity organs, remote metastases, ascites, 
post-chemotherapy status (2017), DIC-syndrome, subacute progress, 
phase of hypocoagulation, toxic liver damage, erosive gastritis, recurrent 
continuing severe gastric hemorrhage, secondary metabolic toxic 
encephalopathy, retinal angiopathy of both  eyes, partial atrophy of cranial 
nerves of both eyes, chronic kidney disease-I (paraneoplastic 
nephropathy), chronic renal failure and severe anemia. 
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The postoperative fibrogastroduodenoscopy revealed an infiltrative form 
of Ca ventriculi and continuous bleeding. Unfortunately, the patient’s 
clinical status progressively worsened and she developed respiratory 
failure and seizures, which resulted in clinical death. Resuscitation 
measures were not effective and biological death was confirmed.  
The autopsy revealed clusters of whitish and yellowish nodules with a 3-5 
mm diameter on the parietal peritoneum, on the thoracic surface of the 
diaphragm and the surface of the intestine’s mesentery. The stomach 
appeared hook shaped. About 150 ml of blood clots and blood masses 
were found in the stomach cavity. The mucous membrane appeared with 
smooth folds. In the area of great curvature and the body of the stomach, 
the wall appeared significantly thickened to 2 cm on an area of 9x9 cm. 
The section presented a dense gray-white tissue and there was an ulcer 
with a 1 cm diameter on the surface of this area. Bloody tarry masses were 
found in the intestine. The liver appeared slightly enlarged and the capsule 
was smooth. On the liver’s surface beneath the capsule, multiple whitish 
nodules with a 2-4 mm diameter were noted and its tissue section 
appeared pale brown. The gallbladder appeared pear-shaped and 
contained about 30 ml of dark bile; the mucous membrane appeared fine-
grained and a whitish induration of 2x2x1 cm was detected at the bottom 
of the bladder. Biliary ducts were patent.  
The microscopic examination of the autopsy material revealed 
proliferation of the signet ring cell carcinoma into all layers of the 
stomach wall (Figure 1a), with ulceration of the mucous membrane. 
Histochemical alcian blue staining revealed accumulation of mucus in the 
cytoplasm of the tumor cells (Figure 1b). 
 
 
 
Figure 1. Gastric signet ring cells carcinoma, patient Z.: a – H&E 
stain; b – alcian blue stain. Original magnification ×100. 
In addition, small metastatic foci of carcinoma were found in the lung and 
subcapsular metastases in the liver, as well as in para-aortic lymph nodes 
and lymph nodes of the greater and lesser omentum and in the fatty tissue 
of the anterior abdominal and gallbladder walls. 
 
The histological examination of the postoperative material revealed 
carcinoma aggregations in the lumen of the cervical vessels and metastatic 
foci in the ovaries. Ischemic infarctions and immature type chorionic villi 
with uneven vascular blood filling were noted in the placental 
parenchyma. Fibrinoid and numerous tumor signet ring cells were 
detected in the intervillous space (Figure 2). 
 
 
Figure 2.  Infiltration of the placental intervillous space with cells of 
the gastric signet ring cells carcinoma. H&E stain. Original 
magnification × 100. 
The immunohistochemical examination of the primary tumor and 
metastatic foci revealed hyperexpression of the СЕА marker (Figure 3a), 
moderate expression of the СK-PAN (Figure 3 b) and СK7 (Figure 3c) 
and selective expression of the СK20 in the single cells (Figure 3d). 
The findings of the histological, histochemical and immunohistochemical 
studies verified gastric signet ring cells carcinoma with multiple 
metastases and infiltration of the placental intervillous space, which 
confirms the data found in the literature [4, 5]. However, the pathogenesis 
of gastric cancer and its relationship with pregnancy remains unclear to 
date. 
 
      
      
Figure 3. Immunohistochemical examination of the gastric signet ring 
cells carcinoma of the patient Z.: а – hyperexpression of the СЕА; b – 
moderate expression of the СК pan; с – moderate expression of the 
СК7; d – selective expression of the СК 20. Original magnification × 
100. 
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3. Discussion  
Malignant tumors during pregnancy are reported in 0.07% - 0.1% of all 
malignant tumors and occur approximately once every 1000 pregnancies 
annually. The most common malignancies during pregnancy are 
melanoma, breast and cervical cancer, lymphoma and leukemia [6]. The 
incidence of gastric cancer in pregnancy is rare. In Japan, a country with a 
high incidence of this type of carcinoma, the rate of gastric cancer during 
pregnancy is reported to be only 0.016% [7]. The 3-year survival rate of 
women diagnosed with gastric cancer during pregnancy does not exceed 
8%, regardless of age and stage of the illness; whereas, the 5-year survival 
rate is accounted for just 2.9%.  
The pathophysiology of pregnancy-related cancer has not been fully 
understood. However, hormonal changes, immunological suppression, 
and increased vascular permeability and vascularization are probably the 
leading factors in its occurrence and progression [6]. 
Gastric cancer is an estrogen-dependent tumor, proved by the 
intensification of the malignant process during pregnancy in clinical 
observations. Estrogenic receptors are present in approximately 22% of 
cells of low-differentiated gastric cancer. Estrogenic hormones are 
mitogens that accelerate cell division. The mitotic effect of estrogens 
increases with the rise of their levels in cells and tissues of estrogen-
sensitive organs and with the increase of their receptor status. In addition, 
estrogens increase the activity of transforming growth factor-α, epidermal 
growth factor and autocrine peptides, each of which is involved in the 
development of a malignant tumor process. Moreover, due to the restored 
form of the enzyme hydroxysteroid dehydrogenase, the activity of which 
is the highest in the tissues of malignant tumors, estrone is converted into 
estradiol, whose mitotic activity is by 5-10 times higher than estrone. 
Tumors also undergo enzymatic conversion by estrone sulfatase, which 
has no regulatory effect on mitosis, to estrone. The 4-OH and 16-OH 
metabolites of estrone and estradiol have a carcinogenic effect, which is 
ensured by genotoxic DNA damage, forming purine-free regions. In 
contrast to target organs such as the mammary gland, estrogenic receptors 
in gastric cancer seem to be a sign of tumor adaptation due to epidermal 
growth factor [8, 9, 10].  
 
4. Conclusions 
Gastric cancer during pregnancy is extremely rare and is usually 
diagnosed during the advanced stages. However, the mortality rate is very 
high when there is the combination of the two conditions, which dictates 
the need to research and improve the methods of early diagnosis of 
malignancies, as well as studying the pathogenesis of malignant tumors in 
pregnant women. Understanding the endocrine mechanisms of carcinoma 
pathogenesis will be useful for developing new therapies for gastric 
cancer. 
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